Page last updated: 2024-12-06

3,5-dichlorobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-dichlorobiphenyl : A dichlorobiphenyl that is 1,3-dichlorobenzene in which the hydrogen at position 5 has been replaced by a phenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID36981
CHEMBL ID125602
CHEBI ID34326
SCHEMBL ID308200
MeSH IDM0095051

Synonyms (27)

Synonym
CHEBI:34326 ,
3,5-dichloro-1,1'-biphenyl
inchi=1/c12h8cl2/c13-11-6-10(7-12(14)8-11)9-4-2-1-3-5-9/h1-8
1,1'-biphenyl, 3,5-dichloro-
3,5-dichlorobiphenyl
34883-41-5
pcb 14
1,3-dichloro-5-phenylbenzene
3,5-dichloro-biphenyl
CHEMBL125602
unii-ixl47709vm
ixl47709vm ,
pcb no 14
AKOS015903319
SCHEMBL308200
QHZSDTDMQZPUKC-UHFFFAOYSA-N
DTXSID5074137 ,
pcb no 14, analytical standard
1,1'-biphenyl, 3,5-dichloro-; biphenyl, 3,5-dichloro- (6ci,7ci); 3,5-dichloro-1,1'-biphenyl; 3,5-dichlorobiphenyl; pcb 14; 3,5-dicb
pcb no. 14
pcb no. 14 10 microg/ml in isooctane
J-019788
tert-butyl?5-bromopyridin-3-ylcarbamate
CS-0190143
Q27115992
E89366
dtxcid5038919
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
dichlorobiphenylAny polychlorobiphenyl with molecular formula C12H8Cl2.
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID89369Transthyretin (TTR) amyloidogenesis inhibition activity by employing an acid-mediated (pH 4.4) WTTTR amyloid fibril formation assay, at 7.2 uM conc.2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]